Watch Ticker

Centessa Pharmaceuticals plc American Depositary Shares

Go to Centessa Pharmaceuticals plc American Depositary Shares Website

$16.70

-0.61 (-3.52%)

Live

Previous Close

$17.31

Day Range

$16.53 - $17.402

Previous Day Range

$15.83 - $17.43

Market Cap

$2.1 billion USD

Day Vol.

168980

Previous Day Vol.

1.6 million

Currency

USD

Primary Exchange

Nasdaq

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arter...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Centessa Pharmaceuticals Announces Clearance of Investigational New Drug Application (IND) for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist; Clinical Data in Acutely Sleep-Deprived Healthy Volunteers Planned for this Year

Centessa Pharmaceuticals announced that the FDA has cleared the IND to initiate a Phase 1 clinical study of ORX142, a novel OX2R agonist, in healthy volunteers. This represents a significant milestone for the company's OX2R agonist pipeline, which also includes ORX750 for the treatment of sleep-wake disorders.

Related tickers: CNTA.

Read Full Article

N/A - Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025

Centessa Pharmaceuticals reported progress in its orexin receptor 2 (OX2R) agonist pipeline, with key data readouts expected in 2025 for ORX750, ORX142, and ORX489. The company's cash position is expected to fund operations into mid-2027.

Related tickers: CNTA.

Read Full Article

Trending Tickers

Please sign in to view